Showing results (131-140 of 324) with videos related to

Sort By:
Pageof 33
International Journal of Radiation Oncology, Biology, Physics|September 1, 1988
Hypoxic cell radiosensitizers in the treatment of high grade gliomas: a new direction using combined Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole)H F Newman, N M Bleehen, R Ward, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 1988
The multi-dose clinical tolerance and pharmacokinetics of the combined radiosensitizers, Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole)H F Newman, R Ward, P Workman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2016
Phosphoproteomics in translational research: a sarcoma perspectiveJ Noujaim, L S Payne, I Judson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
High-dose busulfan in patients with myelomaJ Mansi, F da Costa, C Viner, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1989
A multiple dose study of the combined radiosensitizers Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole)N M Bleehen, H F Newman, T S Maughan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1984
A phase I study of the hypoxic cell radiosensitizer Ro-03-8799J T Roberts, N M Bleehen, P Workman, et al.
Biochemical Pharmacology|March 1, 1983
Drug metabolism and chemosensitization. Nitroimidazoles as inhibitors of drug metabolismP Workman, P R Twentyman, F Y Lee, et al.
Pageof 33